EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers

Quo-Test and Quo-Lab analyzers meet set requirements for determination of HbA1c

EKF Diagnostics, the global diagnostics business, announces the publication of a new white paper detailing the successful external evaluation of its Quo-Test and Quo-Lab glycated hemoglobin (HbA1c) analyzers - ‘Evaluation of four POCT-Systems for the measurement of HbA1c’.

Quo Test
EKF’s Quo-Test HbA1c analyzer is easy-to-use and highly accurate in a POCT setting. Image Credit: EKF Diagnostics

The aim of the study by scientists at IMCARMED GmbH was to compare four point-of-care (POCT) methods with established laboratory techniques for the determination of HbA1c, an internationally recognized biomarker of blood glucose levels for diabetes management. Bringing testing for this biomarker into a POC setting enables real-time monitoring and management of diabetes. Treatment programs utilizing POC HbA1c analysis are able to minimise the number of clinical consultations required and offer a better standard of clinical care to their patients.

The accuracy trial of the four POCT methods was performed with 100 different EDTA blood samples over four days and the results were then compared with those gathered using laboratory-based HPLC and immunological methodologies. Intra-run precision was also examined and all four POCT systems demonstrated good repeatability.

The study concluded that all four POCT systems met the requirements of HbA1c determination in practice and those set by the German Medical Association. EKF’s Quo-Test was noted as being particularly easy-to-use and therefore ideal for use in a POCT setting by non-laboratory trained users. Additionally, with regard to accuracy Quo-Test was found to have the best agreement with both laboratory methods.

The new white paper ‘Evaluation of four POCT-Systems for the measurement of HbA1c’ by Dr Andreas Müller (IMCARMED GmbH) is published online at: www.ekfdiagnostics.com/HbA1c_Analysers_115.aspx.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    EKF Diagnostics. (2024, October 15). EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/news/20131023/EKF-publishes-new-white-paper-detailing-successful-evaluation-of-POCT-HbA1c-analyzers.aspx.

  • MLA

    EKF Diagnostics. "EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers". News-Medical. 21 December 2024. <https://www.news-medical.net/news/20131023/EKF-publishes-new-white-paper-detailing-successful-evaluation-of-POCT-HbA1c-analyzers.aspx>.

  • Chicago

    EKF Diagnostics. "EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers". News-Medical. https://www.news-medical.net/news/20131023/EKF-publishes-new-white-paper-detailing-successful-evaluation-of-POCT-HbA1c-analyzers.aspx. (accessed December 21, 2024).

  • Harvard

    EKF Diagnostics. 2024. EKF publishes new white paper detailing successful evaluation of POCT HbA1c analyzers. News-Medical, viewed 21 December 2024, https://www.news-medical.net/news/20131023/EKF-publishes-new-white-paper-detailing-successful-evaluation-of-POCT-HbA1c-analyzers.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
EKF Diagnostics acquires ADL Health molecular diagnostic testing laboratory